Corvus Pharmaceuticals (CRVS) Ownership

CRVS$10.64+0.02 +0.19%
BiotechnologyValue StockGrowth Stock
Compare
Market cap$897.52MEnterprise value$872.25MRevenue (TTM)$0Market position—

Score

70
Bullish
Value
62
Quality
47
Growth
100

Institutions holding: 125. Ownership 32.65%.

HolderSharesChange %
BLACKROCK, INC.7.10M-0.54%
STATE STREET CORP3.33M-25.54%
VANGUARD CAPITAL MANAGEMENT LLC3.32M+0.80%
VIVO CAPITAL, LLC2.81M0.00%
GEODE CAPITAL MANAGEMENT, LLC1.80M-3.02%
FISHER ASSET MANAGEMENT, LLC1.04M—
MORGAN STANLEY792.71K-41.05%
VANGUARD PORTFOLIO MANAGEMENT LLC787.56K-3.34%
EMERALD ADVISERS, LLC680.02K-0.83%
DCF ADVISERS, LLC641.50K+0.63%
EMERALD MUTUAL FUND ADVISERS TRUST531.34K+0.94%
VANGUARD FIDUCIARY TRUST CO519.26K-0.24%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD.423.26K+94.38%
UBS GROUP AG423.19K+6.83%
BLUE OWL CAPITAL HOLDINGS LP358.60K-41.08%
JUMP FINANCIAL, LLC351.86K+12.27%
PROPEL BIO MANAGEMENT, LLC264.31K—
POLYMER CAPITAL MANAGEMENT (HK) LTD263.66K0.00%
SPRUCE STREET CAPITAL LP231.59K0.00%
SEB ASSET MANAGEMENT AB226.84K0.00%
VOYA INVESTMENT MANAGEMENT LLC196.92K—
BANK OF NEW YORK MELLON CORP196.47K—
BARCLAYS PLC188.24K-40.38%
SEI INVESTMENTS CO181.51K—
F/M INVESTMENTS LLC172.12K—

Corvus Pharmaceuticals (CRVS) Ownership

CRVS price $10.64 +0.02 +0.19%

Ticker
CRVS
Price
$10.64
Change
+0.02 +0.19%
Market cap
$897.52M
Forward P/E
79.55
Dividend yield
0.00%
Beta
0.86
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
70
Value
62
Quality
47
Growth
100

Stocklytics score rationale: value 62, quality 47, growth 100.

Fair value

CRVS fair value $3.77. Price $10.64. Price is 182% above fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price.

Fair value is the earnings value from next-twelve-months EPS times 28.4, a blend of the industry median and the stock's own 10-year median. A cash-flow value is not available for this stock. How we calculate it →

Model uncertainty high for this stock

Compare CRVS

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2027-03-11—-0.24——
2026-11-05-0.22-0.19——
2026-08-06-0.19-0.16——
2026-05-07-0.15-0.14——
2026-03-12-0.15-0.14—775.00K
2025-11-04-0.12-0.14——
2025-08-07-0.10-0.13——
2025-05-08-0.13-0.13——
2025-03-25-0.18-0.12——
2024-11-12-0.60-0.11——
2024-08-06-0.07-0.12——
2024-05-06-0.12-0.12——
2024-03-19-0.14-0.14246.00K—
2023-11-07-0.12-0.16——
2023-08-08-0.14-0.14——
2023-05-08-0.17-0.16——
2023-03-28-0.210.23——
2022-11-03-0.32-0.16——
2022-08-08-0.18-0.19——
2022-05-05-0.18-0.14——
2022-03-10-0.20-0.20——
2021-11-01-0.24-0.30——
2021-08-02-0.28-0.32——
2021-04-29-0.34-0.33——
2021-03-25-0.35-0.32——
2020-10-29-0.33-0.25——
2020-07-30-0.36-0.30——
2020-04-30-0.44-0.40——
2020-03-05-0.38-0.33——
2019-10-29-0.37-0.40——
2019-08-01-0.44-0.42——
2019-05-09-0.40-0.40——
2019-03-07-0.36-0.40——
2018-11-01-0.36-0.46——
2018-08-02-0.40-0.63——
2018-05-03-0.63-0.71——
2018-03-01-0.58-0.66——
2017-11-02-0.62-0.85——
2017-08-03-0.73-0.74——
2017-05-04-0.79-0.77——

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-11-13Arcara JeffreyBuy500$10.715.35K
2026-11-13Arcara JeffreyBuy503$10.375.22K
2026-11-12Arcara JeffreyBuy497$11.125.52K
2026-11-11Arcara JeffreyBuy3.00K$11.4634.38K
2026-06-11Moore David ScottBuy21.70K$11.53250.24K
2026-06-11Moore David ScottBuy15.00K$11.60174.00K
2026-06-11CLARK IAN TBuy15.00K$11.60174.00K
2026-06-11Grais LindaBuy15.00K$11.60174.00K
2026-06-11Thompson Peter A.Buy15.00K$11.60174.00K
2026-06-11van den Broek RichardBuy15.00K$11.60174.00K
2026-05-18MILLER RICHARD A MDBuy1.93K$12.0123.20K
2026-05-18MILLER RICHARD A MDBuy5.00K$12.0560.25K
2026-04-23Chan Andrew C.Buy30.00K$16.02480.60K
2026-04-23Chan Andrew C.Other0——
2026-01-28Thompson Peter A.Buy15.00K$2.1231.80K
2026-01-28Thompson Peter A.Buy15.00K$1.6424.60K
2026-01-28Thompson Peter A.Buy15.00K$2.4937.35K
2026-01-28Thompson Peter A.Buy15.00K$0.9614.47K
2026-01-28Thompson Peter A.Buy15.00K$0.9914.85K
2026-01-28Thompson Peter A.Buy15.00K$2.6039.00K
2026-01-28Thompson Peter A.Buy15.00K$2.7441.10K
2026-01-28Thompson Peter A.Buy15.00K$3.2749.05K
2026-01-28Thompson Peter A.Buy15.00K$2.0030.00K
2026-01-28Thompson Peter A.Buy15.00K$3.6154.15K
2026-01-28Thompson Peter A.Buy15.00K$12.50187.50K
2026-01-28Thompson Peter A.Buy15.00K$9.70145.50K
2026-01-28Thompson Peter A.Buy30.00K$15.00450.00K
2026-01-28Thompson Peter A.Sell15.00K$0.9614.47K
2026-01-28Thompson Peter A.Sell15.00K$0.9914.85K
2026-01-28Thompson Peter A.Sell15.00K$12.50187.50K
2026-01-28Thompson Peter A.Sell30.00K$15.00450.00K
2026-01-28Thompson Peter A.Sell15.00K$1.6424.60K
2026-01-28Thompson Peter A.Sell15.00K$2.1231.80K
2026-01-28Thompson Peter A.Sell15.00K$2.4937.35K
2026-01-28Thompson Peter A.Sell15.00K$2.6039.00K
2026-01-28Thompson Peter A.Sell15.00K$2.7441.10K
2026-01-28Thompson Peter A.Sell15.00K$2.0030.00K
2026-01-28Thompson Peter A.Sell15.00K$3.2749.05K
2026-01-28Thompson Peter A.Sell15.00K$3.6154.15K
2026-01-28Thompson Peter A.Sell15.00K$9.70145.50K
2025-12-04Jones William BentonBuy400.00K$8.813.52M
2025-12-04MILLER RICHARD A MDBuy1.00M$8.818.81M
2025-12-04Arcara JeffreyBuy100.00K$8.81881.00K
2025-12-04LEA LEIVBuy400.00K$8.813.52M
2025-10-02Moore David ScottBuy30.00K$7.04211.20K
2025-10-02Moore David ScottOther0——
2025-06-27ORBIMED ADVISORS LLCBuy1.40M$3.504.89M
2025-06-27ORBIMED ADVISORS LLCSell1.18M$4.164.89M
2025-06-27ORBIMED ADVISORS LLCSell1.40M$3.504.89M
2025-06-27Thompson Peter A.Buy1.40M$3.504.89M
2025-06-27Thompson Peter A.Sell1.18M$4.164.89M
2025-06-27Thompson Peter A.Sell1.40M$3.504.89M
2025-06-12Grais LindaBuy15.00K$4.2463.60K
2025-06-12CLARK IAN TBuy15.00K$4.2463.60K
2025-06-12Morrison Scott WBuy15.00K$4.2463.60K
2025-06-12Thompson Peter A.Buy15.00K$4.2463.60K
2025-06-04Jones William BentonBuy19.36K$3.5067.75K
2025-06-04Jones William BentonSell19.36K$3.5067.75K
2025-05-07MILLER RICHARD A MDBuy559.07K$3.501.96M
2025-05-07MILLER RICHARD A MDSell559.07K$3.501.96M
2025-04-08van den Broek RichardBuy30.00K$2.8284.60K
2025-04-08van den Broek RichardOther0——
2024-12-20Arcara JeffreyBuy50.00K$4.99249.50K
2024-12-20Jones William BentonBuy300.00K$4.991.50M
2024-12-20LEA LEIVBuy300.00K$4.991.50M
2024-12-20MILLER RICHARD A MDBuy750.00K$4.993.74M
2024-06-13Grais LindaBuy15.00K$2.1231.80K
2024-06-13CLARK IAN TBuy15.00K$2.1231.80K
2024-06-13Morrison Scott WBuy15.00K$2.1231.80K
2024-06-13Gould Terry PBuy15.00K$2.1231.80K
2024-06-13Thompson Peter A.Buy15.00K$2.1231.80K
2024-05-10MILLER RICHARD A MDSell302.02K——
2024-05-06Thompson Peter A.Buy1.44M$0.00144
2024-05-06Thompson Peter A.Buy1.40M$3.504.89M
2024-05-06ORBIMED ADVISORS LLCBuy1.44M$0.00144
2024-05-06ORBIMED ADVISORS LLCBuy1.40M$3.504.89M
2024-05-06Jones William BentonBuy20.00K$1.7334.62K
2024-05-06Jones William BentonBuy19.36K$3.5067.75K
2024-05-06MILLER RICHARD A MDBuy577.63K$1.731000.00K
2024-05-06MILLER RICHARD A MDBuy559.07K$3.501.96M
2024-02-28Arcara JeffreyBuy400.00K$2.30920.00K
2024-02-02Arcara JeffreyOther0——
2023-12-06MILLER RICHARD A MDBuy500.00K$1.64820.00K
2023-12-06LEA LEIVBuy200.00K$1.64328.00K
2023-12-06Jones William BentonBuy200.00K$1.64328.00K
2023-12-06Mitchell Edith P.Buy15.00K$1.6424.60K
2023-12-06Grais LindaBuy15.00K$1.6424.60K
2023-12-06CLARK IAN TBuy15.00K$1.6424.60K
2023-12-06Morrison Scott WBuy15.00K$1.6424.60K
2023-12-06Gould Terry PBuy15.00K$1.6424.60K
2023-12-06Thompson Peter A.Buy15.00K$1.6424.60K
2023-06-15Thompson Peter A.Buy15.00K$2.4937.35K
2023-06-15Gould Terry PBuy15.00K$2.4937.35K
2023-06-15CLARK IAN TBuy15.00K$2.4937.35K
2023-06-15Morrison Scott WBuy15.00K$2.4937.35K
2023-06-15Grais LindaBuy15.00K$2.4937.35K
2023-06-15Mitchell Edith P.Buy15.00K$2.4937.35K
2023-05-15Grais LindaBuy10.00K$2.4524.50K
2023-03-31MILLER RICHARD A MDBuy800.00K$0.91728.00K
2022-12-20Jones William BentonBuy20.00K$0.7915.80K

Institutional holders

Latest filed quarter: Q3 2026.

Institutions holding: 125, holders -63 vs prior quarter. Ownership 32.65%.

HolderSharesChangeChange %Value
BLACKROCK, INC.7.10M-38.41K-0.54%81.80M
STATE STREET CORP3.33M-1.14M-25.54%38.38M
VANGUARD CAPITAL MANAGEMENT LLC3.32M26.36K+0.80%38.24M
VIVO CAPITAL, LLC2.81M00.00%32.32M
GEODE CAPITAL MANAGEMENT, LLC1.80M-55.95K-3.02%20.72M
FISHER ASSET MANAGEMENT, LLC1.04M1.04MNew11.99M
MORGAN STANLEY792.71K-552.02K-41.05%9.13M
VANGUARD PORTFOLIO MANAGEMENT LLC787.56K-27.19K-3.34%9.07M
EMERALD ADVISERS, LLC680.02K-5.67K-0.83%7.83M
DCF ADVISERS, LLC641.50K4.00K+0.63%7.39M
EMERALD MUTUAL FUND ADVISERS TRUST531.34K4.95K+0.94%6.12M
VANGUARD FIDUCIARY TRUST CO519.26K-1.27K-0.24%5.98M
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD.423.26K205.51K+94.38%4.88M
UBS GROUP AG423.19K27.07K+6.83%4.88M
BLUE OWL CAPITAL HOLDINGS LP358.60K-250.00K-41.08%4.13M
JUMP FINANCIAL, LLC351.86K38.46K+12.27%4.05M
PROPEL BIO MANAGEMENT, LLC264.31K264.31KNew3.04M
POLYMER CAPITAL MANAGEMENT (HK) LTD263.66K00.00%3.04M
SPRUCE STREET CAPITAL LP231.59K00.00%2.67M
SEB ASSET MANAGEMENT AB226.84K00.00%2.61M
VOYA INVESTMENT MANAGEMENT LLC196.92K196.92KNew2.27M
BANK OF NEW YORK MELLON CORP196.47K196.47KNew2.26M
BARCLAYS PLC188.24K-127.51K-40.38%2.17M
SEI INVESTMENTS CO181.51K181.51KNew2.09M
F/M INVESTMENTS LLC172.12K172.12KNew1.98M

Insights · Forecast · Financials · Learn

Stocklytics home · Screener